PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

Name: PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML
License: Public Domain

The First Affiliated Hospital of Soochow University

ClinicalTrials.gov · Datasets · License: Public Domain

immunotherapy, refractory leukemia, relapsed adult aml, acute myeloid leukemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 426779
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.